Nervgen pharma announces results of annual general meeting of shareholders

All resolutions submitted for approval were passed by shareholders vancouver, british columbia--(newsfile corp. - may 7, 2025) - nervgen pharma corp. (tsxv: ngen) (otcqb: ngenf), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, announces the results of its annual general meeting of shareholders ("agm") held on may 6, 2025. the company reports that at the agm the shareholders re-elected brian bayley, harold punnett, randall kaye, krista mckerracher, glenn ives, craig thompson, adam rogers, john ruffolo, neil klompas and michael kelly to serve in office until the next annual meeting or until their successors are duly elected or appointed.
GM Ratings Summary
GM Quant Ranking